WILMINGTON, DE / ACCESSWIRE / June 23, 2023 / The global radiation proctitis market is estimated to expand at a CAGR of ~7% during the forecast period from 2020 to ...
(MENAFN- Ameliorate Digital Consultancy) Radiation proctitis is a condition that affects the rectum and is caused by radiation therapy. The condition can cause symptoms such as rectal bleeding, pain, ...
NEW YORK, NY --(Marketwired - April 29, 2015) - The following is a statement issued by Expert Jeffrey Davis, COO, PlasmaTech Biopharmaceuticals (PTBI): Radiation Proctitis ("RP") is a term used to ...
The radiation proctitis treatment market refers to the sales of products and services used for the treatment of radiation proctitis, a condition that affects the rectum and lower colon. Radiation ...
Prospects for 2021 appear to be largely optimistic, according to Fact.MR projections. Long-term prospects appear promising, with a CAGR of around 7% projected for the next ten years and a market ...
Chronic radiation proctitis produces a range of clinical symptoms for which there is currently no recommended standard management. The aim of this review was to identify the various non-surgical ...
According to Fact MR’s recent market research, Radiation Proctitis Treatment sales to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues ...
The management of radiation proctitis and related complications remains a significant clinical challenge, given the complex interplay between acute mucosal injury and chronic inflammatory processes ...
ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard™, for the treatment of radiation proctitis. Radiation proctitis ...
The fixed anatomical position of the rectum in the pelvis and the close proximity to the prostate, cervix, and uterus makes the rectum quite vulnerable to injury from secondary radiation resulting in ...
As per the Fact.MR’s report, the Demand for Radiation Proctitis Treatment is poised to reach nearly US$ 750 million by 2031, expanding at approximately 7% CAGR over the next ten years. The sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback